Details for Patent: 7,875,637
✉ Email this page to a colleague
Title: | Benzimidazole derivative and use as a II receptor antagonist |
Abstract: | The present invention relates to a compound represented by the formula (I) ##STR00001## wherein R.sup.1 is a group represented by the formula ##STR00002## wherein R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7 and R.sup.8 are each independently a hydrogen atom or a C.sub.1-6 alkyl, or a salt thereof. The compound of the present invention is useful as an agent for the prophylaxis or treatment of circulatory diseases such as hypertension and the like and metabolic diseases such as diabetes and the like. |
Inventor(s): | Kuroita; Takanobu (Katano, JP), Sakamoto; Hiroki (Amagasaki, JP), Ojima; Mami (Amagasaki, JP) |
Assignee: | Takeda Pharmaceutical Company Limited (Osaka, JP) |
Filing Date: | Jun 30, 2009 |
Application Number: | 12/458,092 |
Claims: | 1. A method for improving insulin resistance in a mammal, which comprises administering an effective amount of (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-{[T-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]meth- yl}-1H-benzimidazole-7-carboxylate, or a pharmaceutically acceptable salt thereof to said mammal in need thereof. 2. A method for treating of diseases in which insulin resistance is involved in a mammal, which comprises administering an effective amount of (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]met- hyl}-1H-benzimidazole-7-carboxylate, or a pharmaceutically acceptable salt thereof to said mammal in need thereof. 3. A method for treating of diseases in which insulin resistance is involved in a mammal, which comprises administering an effective amount of (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]met- hyl}-1H-benzimidazole-7-carboxylate, or a pharmaceutically acceptable salt thereof in combination with a calcium antagonist to said mammal in need thereof. 4. A method for treating of diseases in which insulin resistance is involved in a mammal, which comprises administering an effective amount of (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]met- hyl}-1H-benzimidazole-7-carboxylate, or a pharmaceutically acceptable salt thereof in combination with an insulin sensitizer to said mammal in need thereof. 5. A method for treating of diseases in which insulin resistance is involved in a mammal, which comprises administering an effective amount of (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]met- hyl}-1H-benzimidazole-7-carboxylate, or a pharmaceutically acceptable salt thereof in combination with a biguanide to said mammal in need thereof. |